Peters Brandilyn A, Liu Xinhua, Hall Megan N, Ilievski Vesna, Slavkovich Vesna, Siddique Abu B, Alam Shafiul, Islam Tariqul, Graziano Joseph H, Gamble Mary V
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
Free Radic Biol Med. 2015 Aug;85:174-82. doi: 10.1016/j.freeradbiomed.2015.04.020. Epub 2015 Apr 24.
Exposure to arsenic (As) in drinking water is a widespread public health problem leading to increased risk for multiple outcomes such as cancer, cardiovascular disease, and possibly renal disease; potential mechanisms include inflammation and oxidative stress. We tested the hypothesis that As exposure is associated with increased inflammation and decreased estimated glomerular filtration rate (eGFR) and examined whether the effects of As were modified by plasma glutathione (GSH), glutathione disulfide (GSSG), or the reduction potential of the GSSG/2GSH pair (EhGSH). In a cross-sectional study of N = 374 Bangladeshi adults having a wide range of As exposure, we measured markers of inflammation (plasma C-reactive protein (CRP), α-1 acid glycoprotein (AGP)), renal function (eGFR), GSH, and GSSG. In covariate-adjusted models, a 10% increase in water As, urinary As adjusted for specific gravity (uAs), or blood As (bAs) was associated with a 0.74% (p = 0.01), 0.90% (p = 0.16), and 1.39% (p = 0.07) increase in CRP, respectively; there was no association with AGP. A 10% increase in uAs or bAs was associated with an average reduction in eGFR of 0.16 (p = 0.12) and 0.21 ml/min/1.73 m(2) (p = 0.08), respectively. In stratified analyses, the effect of As exposure on CRP was observed only in participants having EhGSH > median (uAs p(Wald) = 0.03; bAs p(Wald) = 0.05). This was primarily driven by stronger effects of As exposure on CRP in participants with lower plasma GSH. The effects of As exposure on eGFR were not modified significantly by EhGSH, GSH, or GSSG. These data suggest that participants having lower plasma GSH and a more oxidized plasma EhGSH are at increased risk for As-induced inflammation. Future studies should evaluate whether antioxidant treatment lowers plasma EhGSH and reduces risk for As-induced diseases.
饮用水中砷(As)的暴露是一个普遍存在的公共卫生问题,会导致多种不良后果的风险增加,如癌症、心血管疾病以及可能的肾脏疾病;潜在机制包括炎症和氧化应激。我们检验了以下假设:砷暴露与炎症增加和估计肾小球滤过率(eGFR)降低有关,并研究了血浆谷胱甘肽(GSH)、谷胱甘肽二硫化物(GSSG)或GSSG/2GSH对的还原电位(EhGSH)是否会改变砷的影响。在一项对374名砷暴露范围广泛的孟加拉国成年人进行的横断面研究中,我们测量了炎症标志物(血浆C反应蛋白(CRP)、α-1酸性糖蛋白(AGP))、肾功能(eGFR)、GSH和GSSG。在协变量调整模型中,水中砷、经比重校正的尿砷(uAs)或血砷(bAs)每增加10%,分别与CRP增加0.74%(p = 0.01)、0.90%(p = 0.16)和1.39%(p = 0.07)相关;与AGP无关联。uAs或bAs每增加10%,分别与eGFR平均降低0.16(p = 0.12)和0.21 ml/min/1.73 m²(p = 0.08)相关。在分层分析中,仅在EhGSH > 中位数的参与者中观察到砷暴露对CRP的影响(uAs p(Wald)= 0.03;bAs p(Wald)= 0.05)。这主要是由于血浆GSH较低的参与者中,砷暴露对CRP的影响更强。EhGSH、GSH或GSSG对砷暴露对eGFR的影响没有显著改变。这些数据表明,血浆GSH较低且血浆EhGSH氧化程度较高的参与者发生砷诱导炎症的风险增加。未来的研究应评估抗氧化治疗是否会降低血浆EhGSH并降低砷诱导疾病的风险。